Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Glial Cells01:04

Glial Cells

Overview
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RE-ARMing the Immune Response to Bladder Cancer with Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Is There a Benefit of Combining Immunotherapy and Radiotherapy in Bladder Cancer?

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021
Same author

Glucocorticoid and inflammatory reactivity to a repeated physiological stressor in insomnia disorder.

Neurobiology of sleep and circadian rhythms·2019
Same author

Science in Focus: Biological Optimisation of Radiotherapy Fraction Size in an Era of Immune Oncology.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018
Same author

Neurosarcoidosis: a clinical approach to diagnosis and management.

Journal of neurology·2016
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Protecting axons in multiple sclerosis.

A Wilkins1, N Scolding

  • 1Department of Neurology, Institute of Clinical Neurosciences, University of Bristol, Frenchay Hospital, Bristol, UK. alastair.wilkins@bristol.ac.uk

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 18, 2008
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) patients experience neurological decline due to axon damage. Current treatments don't fully address this progressive axonopathy, indicating unknown underlying mechanisms beyond inflammation.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Related Experiment Videos

Last Updated: Jul 3, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Area of Science:

  • Neuroscience
  • Immunology
  • Neurology

Background:

  • Multiple sclerosis (MS) is characterized by acute neurological episodes and progressive disability.
  • Disease progression in MS involves central nervous system axon damage and loss.
  • The exact mechanisms driving axon injury in MS remain unclear.

Purpose of the Study:

  • To investigate the precise mechanisms of axon injury in multiple sclerosis.
  • To understand the relationship between inflammation and progressive axonopathy in MS.
  • To identify potential therapeutic targets for halting MS disease progression.

Main Methods:

  • Review of epidemiological data and treatment studies in MS patients.
  • Analysis of the dissociation between inflammation and disease progression.
  • Exploration of potential degenerative processes contributing to axon loss.

Main Results:

  • Inflammation during relapses causes acute axon damage but doesn't fully explain long-term progression.
  • Immune suppression fails to halt progression in patients with established disability.
  • The progressive loss of neurological function suggests a degenerative component independent of acute inflammation.

Conclusions:

  • Axonopathy in MS is multifactorial, involving more than just acute inflammatory events.
  • Understanding the degenerative mechanisms is crucial for developing effective therapies for MS progression.
  • Further research is needed to elucidate the precise causes of ongoing axon loss in MS.